OLUKOTUN ADEOYE Y
SEC Form 4 insider trading activity
OLUKOTUN ADEOYE Y has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Aug 20, 2026.
On the most recent filing, OLUKOTUN ADEOYE Y is listed as Director at ARROWHEAD PHARMACEUTICALS, INC. Inside the rolling window, OLUKOTUN ADEOYE Y reported no open-market purchases and 2 open-market sales totaling $851K in ARWR. The largest disclosed transaction in the window is a sale of 10,000 ARWR shares on Dec 19, 2025, worth $677K.
Companies traded
Other insiders at ARWR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$851K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has OLUKOTUN ADEOYE Y made?
OLUKOTUN ADEOYE Y has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does OLUKOTUN ADEOYE Y trade?
OLUKOTUN ADEOYE Y has filed SEC Form 4 disclosures for 1 company, including ARWR.
When was OLUKOTUN ADEOYE Y's most recent SEC Form 4 filing?
OLUKOTUN ADEOYE Y's most recent SEC Form 4 filing on Tracefour is dated Aug 20, 2026.
What is OLUKOTUN ADEOYE Y's total buy and sell value in the current window?
Inside the rolling retention window, OLUKOTUN ADEOYE Y bought $0 and sold $851K based on SEC Form 4 filings.
What was OLUKOTUN ADEOYE Y's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,000 ARWR shares on 2025-12-19, worth $677K, per SEC Form 4 filings.